Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database

Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study

(2018) Noel Frey et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs

(2017) Noel Frey et al.   EPILEPSIA

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK

(2017) Noel Frey et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

(2017) Carlos González-Herrada et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Fever in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases

(2017) Maren Paulmann et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults

(2016) Derek Y. Hsu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Epidermal necrolysis: 60 years of errors and advances

(2015) Y.K. Heng et al.   BRITISH JOURNAL OF DERMATOLOGY

Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study

(2015) Elisa Martín-Merino et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry

(2015) Janouk Diphoorn et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies

(2012) H.Y. Lee et al.   BRITISH JOURNAL OF DERMATOLOGY

Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France

(2012) Nicholas Moore et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The Case-Population Study Design

(2011) Hélène Théophile et al.   DRUG SAFETY

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

(2010) B Sassolas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

(2007) Sima Halevy et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY